Hyundai Pharmaceutical Co., Ltd. (KOSE: A004310)
Health Care · Pharmaceuticals · KR
₩8,340.00
-5.87% today · +117.2% 1Y
Hyundai Pharmaceutical Co., Ltd. (KOSE: A004310) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $171.40M.
Over the last twelve months the share price has gained 117.2%, trading between 3.50K and 15.96K.
Tweenvest scores Hyundai Pharmaceutical Co., Ltd. across four factors: quality 77/100, value 5/100, dividend 45/100. Its strongest factor is quality.
A004310 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $171.40M
- Revenue (TTM)
- $102.19M
- P/E
- 138.22
- EPS
- 60.34
- Dividend yield
- 0.36%
- Beta (5Y)
- 0.68
- 52-week high
- ₩15,960.00
- 52-week low
- ₩3,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 27.68M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MediWound Ltd.NasdaqGM: MDWD | $174.55M | $12.85 | -4.96% |
| IT-Chem CO.,LtdKOSDAQ: A309710 | $173.78M | ₩— | — |
| Samjin Pharmaceuticals Co., Ltd.KOSE: A005500 | $173.66M | ₩19,080.00 | +3.41% |
| Zhaoke Ophthalmology LimitedSEHK: 6622 | $173.23M | HK$2.49 | -1.19% |
| Binh Dinh Pharmaceutical and Medical Equipment Joint Stock CompanyHOSE: DBD | $170.00M | ₫46,750.00 | -0.43% |
| Kahira Pharmaceuticals & Chemical Industries CompanyCASE: CPCI | $169.94M | EGP595.69 | +6.11% |
| JBM (Healthcare) LimitedSEHK: 2161 | $169.74M | HK$1.63 | +0.31% |
| Mecure Industries PLCNGSE: MECURE | $169.26M | ₦56.20 | -9.94% |
Figures last refreshed Oct 4, 2026.